July 6, 2021 Clinical Research Ontario study reports that one dose is good but two doses are better against variants. Keep on keeping on. #vaccineswork
June 22, 2021 Clinical Research Preprint longitudinal controlled MRI-imaging study notes direct evidence of brain abnormalities in people who had COVID (matched and compared to those did not) that could explain the symptoms of Long-COVID. #LongHaulers #LongCovid #VaccinesWork
May 27, 2021 Allergy/Immunology German study proposes a mechanism behind the rare blood clots associated with AstraZeneca vaccine.
May 19, 2021 Clinical Research For those who have had AstraZeneca as their first dose, small Spanish study shows that using Pfizer as the second dose is safe and effective. More evaluation and other trials are ongoing but still, good news.
May 14, 2021 Clinical Research Give research the time to answer the question about the need for yearly Covid-19 vaccine boosters given that variants, present and future, will continue to be an issue for a while. Speculation is a mug’s game. Evidence is better.
May 13, 2021 Clinical Research Short-lived common side effects including fever, chills, pain, and headache after mixing AZ with Pfizer vaccine reported in @TheLancet. Immunogenicity results to be reported in June and if mixing is a viable option (likely but assumption needs evidence).
May 6, 2021 Allergy/Immunology Jury still out on mixing and matching vaccines. Picture to become much clearer very soon with studies to come but assumption is that it should work given existing vaccines stimulate production of the spike protein with similar endpoint efficacy.
May 5, 2021 Clinical Research U.K. planning to give third Covid booster dose alongside the flu vaccine to people over 50 in the Fall. Studies looking at new variant-adjusted vaccine versus existing one to be used in this process.
May 3, 2021 Allergy/Immunology The development of mRNA vaccine technology has the potential to expand to treat and prevent other diseases akin to the technological spinoffs seen with the Apollo space program.
April 30, 2021 Clinical Research Preprint study evaluated entire Scottish population and calls into question delaying second Covid vaccine dose up to 12 weeks. After first dose it noted a drop in preventing hospitalization from 84% at 5 weeks to 58% after the 7th. And after 16 weeks?
